US OptionsDetailed Quotes

TMDX240517C75000

Watchlist

56.40
0.000.00%

15min DelayClose May 17 16:00 ET

0.00High0.00Low

TransMedics Stock Discussion

Pongz

May 1 00:31

$TransMedics(TMDX.US)$ more than 13% increase duruing post-market is unbelievable.

Moomoo AI

Mar 11 09:53

TransMedics Group's trend of growing ROCE and increasing capital employed suggests profitable reinvestment opportunities, potentially leading to a multi-bagger performance. The stock's solid return to shareholders over the last three years indicates investor recognition of these changes.

The Return Trends At TransMedics Group (NASDAQ:TMDX) Look Promising

Rockyturki

Mar 10 22:19

$Advanced Micro Devices(AMD.US)$ was obvious to buy at $100 and many waited
$Celsius Holdings(CELH.US)$ at $48 (this year) was the easiest money and people waited.
$Palantir(PLTR.US)$ at $14 was extremely undervalued and many waited
$Meta Platforms(META.US)$ was obvious to buy at $200 and everyone waited
$CrowdStrike(CRWD.US)$ was a clear buy at $150 and people waited
$TransMedics(TMDX.US)$ at $38 with a market cap of $1 Billion was a steal and nobody wanted to buy it.
Focus on the essentials: align...

Kevin Travers

Feb 27 10:02

ColumnsBiotechnology Stocks Climbing on Earnings and Test Results: What to Watch

$Viking Therapeutics (VKTX.US)$skyrocketed 77% after positive drug trial news Tuesday, leading to what proved to be a strong morning for pharmaceutical stocks.
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...

Moomoo AI

Jan 25 08:59

Insider selling over the past year, particularly in recent months, may indicate insiders believe shares are overpriced. Despite some insider buying, the long-term outlook lacks positivity. Insider ownership shows alignment with shareholders, but past sales warrant caution.

TransMedics Group Insiders Sell US$2.1m Of Stock, Possibly Signalling Caution

Moomoo AI

Dec 14, 2023 06:08

TransMedics Group's significant top-line growth is undermined by its negative EBIT, liabilities outstripping cash and near-term receivables by $75m, and increased cash burn over the past year, constituting substantial risk.

Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?

Moomoo AI

Nov 7, 2023 07:59

Oppenheimer analysts hail TransMedics' recent quarter as 'blockbuster', emphasizing its long-term strategy to overcome short term challenges. The game-changing potential of the Organ Care System technology to reshape organ preservation and transport is also highlighted.

TransMedics' Stock Pops After Organ-transplant Company's 'Blockbuster' Third-quarter Results

Pinchie McPincher

Nov 7, 2023 04:03

wheres everyone
and why did this run up all on its own

Moomoo AI

Oct 10, 2023 06:54

Positive interpretation of recent purchases at TransMedics Group amidst potential concerns over last year's sales. Insiders' stakes display alignment between management and smaller shareholders.

TransMedics Group Insiders Sold US$1.9m Of Shares Suggesting Hesitancy

Cramer ETF

Jan 19, 2023 01:03

Cramer’s lightning round: TransMedics is a total winner $TransMedics(TMDX.US)$

No comment yet